SCA
NXTM

Secor Capital Advisors’s NxStage Medical Inc. NXTM Stock Holding History

Secor Capital Advisors’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-12,569
Closed -$188K – 770
2016
Q1 		$188K Buy
+12,569
New +$211K 0.03% 554

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Secor Capital Advisors's NXTM Position: Q2 2016 in Review

Secor Capital Advisors sold out of NxStage Medical Inc. (NXTM) in Q2 2016, closing a stake of 12,569 shares — an estimated $188K sold.

Secor Capital Advisors first reported a position in NXTM in Q1 2016 and held it in 1 quarter. The position peaked at $188K in Q1 2016. 147 funds tracked by Wall St. Rank hold NXTM as of Q2 2016.

  • Secor Capital Advisors reported no remaining NxStage Medical Inc. position as of Q2 2016 after selling out during the quarter.
  • Secor Capital Advisors sold 12,569 NxStage Medical Inc. shares in Q2 2016, an estimated $188K.
  • Secor Capital Advisors first reported a position in NxStage Medical Inc. in Q1 2016 and held it in 1 quarter.
  • Secor Capital Advisors's NxStage Medical Inc. position peaked at $188K in Q1 2016.
  • 147 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2016.

Based on Secor Capital Advisors's 13F filing for Q2 2016, filed 9 Aug 2016.